rb 101 has been researched along with morphinans in 1 studies
Studies (rb 101) | Trials (rb 101) | Recent Studies (post-2010) (rb 101) | Studies (morphinans) | Trials (morphinans) | Recent Studies (post-2010) (morphinans) |
---|---|---|---|---|---|
57 | 0 | 2 | 3,251 | 307 | 648 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
FourniƩ-Zaluski, MC; Noble, F; Roques, BP; Turcaud, S | 1 |
1 other study(ies) available for rb 101 and morphinans
Article | Year |
---|---|
Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine.
Topics: Analgesics; Animals; Disulfides; Dose-Response Relationship, Drug; Drug Tolerance; Indoles; Male; Mice; Morphinans; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Phenylalanine; Prodrugs; Reaction Time | 1992 |